1-3 of 3
Elisa Forti
Close
Sort by
Journal Articles

Clinico-Pathological, Cytogenetic and Molecular Similarities and Differences between Primary and Secondary Cutaneous Lymphomas

Silvia Uccella, Gaia Goteri, Antonino Maiorana, Valentina Donati, Maria Grazia Tibiletti, Francesca Magnoli, Sofia Facchi, Deborah Merchiori, Erika Morsia, Robel Papotti, Stefania Bettelli, Elisa Forti, Sara Galimberti, Serena Rupoli, Alessandra Filosa, Dimitri Dardanis, Luca Braglia, Samantha Pozzi, Stefano Sacchi
Journal: Blood
Blood (2022) 140 (Supplement 1): 11887–11888.
https://doi.org/10.1182/blood-2022-166554
Published: 2022
Journal Articles

COO, MYC / BCL2 Status and R-IPI Define a Group of Poor Prognosis DLBCL Patients in a Real-World Clinical Setting

Stefania Bettelli, Raffaella Marcheselli, Samantha Pozzi, MD, Luigi Marcheselli, Robel Papotti, Elisa Forti, M. Christina Christina Cox, MD PhD, Arianna Di Napoli, Tamar Tadmor, MD, Antonino Maiorana, Valentina Donati, MD, Sara Galimberti, MD PhD, Stefano Sacchi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1617.
https://doi.org/10.1182/blood-2019-125689
Published: 2019
Journal Articles

Prognostication of Diffuse Large B-Cell Lymphoma By Lympho2Cx Assay and BCL2 and MYC Expression: Application in a Real Life Context of 154 Patients

Stefania Bettelli, Raffaella Marcheselli, Samantha Manfredini, Alessia Bari, MD, Samantha Pozzi, MD, M. Christina Christina Cox, MD PhD, Luigi Marcheselli, Arianna Di Napoli, Ilana Levy, MD, Elisa Forti, Tamar Tadmor, MD, Antonino Maiorana, Stefano Sacchi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5308.
https://doi.org/10.1182/blood-2018-99-117973
Published: 2018